---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-006594"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T10:04:38.790923+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne Q3 revenue $316.2M (+6% organic), adj EPS $0.56, declares $0.08 dividend and $500M buyback

## Summary
- Q3 organic revenue +6% to $316.2M; GAAP EPS $0.14 vs $0.31 YoY; adjusted EPS $0.56 vs $0.48 YoY.
- Protein Sciences segment organic growth 7% (reported 6%) on improved pharma demand and commercial execution.
- Adjusted operating margin improved to 34.9% from 33.0% YoY; reported margin 12.2% (incl. charges).
- Declared quarterly dividend $0.08/share, payable May 30, 2025 to holders of record May 19, 2025.
- Board approved new $500M share repurchase program, effective May 8, 2025, replacing prior program.

## SEC filing metadata
- accession: 0001558370-25-006594
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837025006594/0001558370-25-006594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837025006594/tech-20250507x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-006594
- JSON: https://secwatch.observer/filing/0001558370-25-006594.json
- Plain text: https://secwatch.observer/filing/0001558370-25-006594.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.